Latest Top 20 Read Articles

1. Letter to the Editor:

Alessandro Monaco, Federica Mammarella, Agnese Cangini, Roberto Marini, Alessandra Marengoni, Pierluigi Russo, Sergio Pecorelli and Luca Pani

Generic and biosilimilar medicines use and expenditure: A report from the National Observatory on the Use of Medicines (OsMed) of the Italian Medicines Agency (AIFA)

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

June 2015 12: 79–80, first published on November 26, 2015, doi:10.1177/1741134315618535

2. Letter to the Editor:

G Smith, JA Smith and DA Brindley

The Falsified Medicines Directive: How to secure your supply chain

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

September–December 2014 11: 169–172, first published on June 1, 2015, doi:10.1177/1741134315588986

3. Editorial:

Maria Fabiana Jorge

Would the Trans-Pacific Partnership Agreement undermine Japan’s efforts to control health care expenditures?

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

September–December 2013 10: 147, first published on November 19, 2014, doi:10.1177/1741134314558353

4. Editorial:

Brian W Tempest

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

September–December 2014 11: 97, doi:10.1177/1741134315592208

5. Editorial:

Brian W Tempest

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

March 2015 12: 3, doi:10.1177/1741134315619286

6. Editorial:

Brian W Tempest

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

June 2015 12: 45, doi:10.1177/1741134315627332

7. Original Paper:

David Jauch and Sergio Napolitano

How the generic and biosimilar medicines industry could take advantage of trade opportunities

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

June 2015 12: 46–49, first published on December 31, 2015, doi:10.1177/1741134315622969

8. Original Paper:

Susan Capie

China's pharmaceutical revolution and emerging contenders

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

January 2007 4: 98–105, doi:10.1057/palgrave.jgm.4950059

 9.Original Paper:

P Grootendorst and A Hollis

The 2011 Canada-European Union Comprehensive Economic and Trade Agreement: An economic impact assessment of the EU’s proposed pharmaceutical intellectual property provisions

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

April 2011 8: 81–103, doi:10.1177/1741134311408275

10. Editorial:

María Fabiana Jorge

Trade agreements that raise barriers to entry and hinder innovation: Is that what we are seeking in current trade agreements?

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

March 2013 10: 3, doi:10.1177/1741134313485615

11. Original Paper:

María Fabiana Jorge

TRIPS-Plus provisions in trade agreements and their potential adverse effects on public health

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

April 2004 1: 199–211, doi:10.1057/palgrave.jgm.4940023

12. Original Paper:

Nabil Abdo Al-Gedadi and Mohamed Azmi Hassali

Pharmacists' views on generic medicines: A review of the literature

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

April 2008 5: 209–218, doi:10.1057/jgm.2008.7

13. Editorial:

Dilip G Shah

Innovation, IPRs and investment

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

January 2008 5: 95–97, doi:10.1057/palgrave.jgm.4950097

14. Original Paper:

Pieter Dylst, Arnold Vulto, and Steven Simoens

Overcoming challenges in market access of generic medicines in the European Union

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

March 2012 9: 21–28, doi:10.1177/1741134312441107

15. Editorial:

Maria Fabiana Jorge

Biologic drugs: How to design a sustainable system?

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

June 2013 10: 71, doi:10.1177/1741134314529694

16. Original Paper:

Steven Simoens and Sandra De Coster

Sustaining generic medicines markets in Europe

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

July 2006 3: 257–268, doi:10.1057/palgrave.jgm.4940128

17. Editorial:

Maria Fabiana Jorge

The pharmaceutical market of the future: Will there be unfair delays for the entry of generics in the biotechnology era?

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

August 2009 6: 293–294, doi:10.1057/jgm.2009.31

18. Editorial:

María Fabiana Jorge

When policy coherence matters: Are EU trade agreements on intellectual property rights undermining access to affordable medicines?

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

October 2010 7: 301–303, doi:10.1057/jgm.2010.28

19. Editorial:

Maria Fabiana Jorge

The generic industry is changing and will require new global strategies and policies

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

February 2009 6: 97–98, doi:10.1057/jgm.2009.3

20. Original Paper:

Baobin Huang, Sarah L Barber, Milan Smid, Patrick Hoet, Alain Kupferman, Jim Sun, and Chunfu Wu

Technical gaps faced by Chinese generic medicine manufacturers to achieve the standards of WHO medicines Prequalification

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

March 2013 10: 14–21, doi:10.1177/1741134313483748